There are 15,358 results relating to "Medicin Viagra-m"
Order by
|
Questions and Answers
Date answered:
2 July 2004
S2W-09164
Therefore the rules of this scheme should notaffect the supply of prescription only veterinary medicines. S2W-09164
Questions and Answers
Date answered:
2 October 2003
S2O-00549
To ask the Scottish Executive how many drugs have been banned and withdrawn from use since April 2002. The safety of medicines is areserved matter and is the responsibility of the Medicines and Healthcare productsRegulatory Agency.The agency has advised that preparationscontaining the herbal ingredient Kava kava, ex...
Questions and Answers
Date answered:
14 January 2003
S1W-32846
There is no barrier to the provision of complementary medicine through the NHS in Scotland. Decisions on whether to provide any particular form of complementary medicine are for NHS boards to make, based on their assessment of local needs.
Questions and Answers
Date answered:
5 February 2002
S1W-22150
To ask the Scottish Executive whether it has any plans to instruct NHS boards to make any drugs available to clinicians before such drugs have been approved by the National Institute for Clinical Excellence and the Health Technology Board for Scotland. The Scottish Medicines Consortium (SMC) will make recommendations to all NHS Boards and their Area Drug and Therapeutics Committees about the formulary status of all newly licensed medicines, all new formulations of existing medicines and any major new indications for established products.
Questions and Answers
Date answered:
26 May 2005
S2W-16491
The Medicines for Human Use (Clinical Trials) Regulations 2004 introduce new requirements in relation to the approval and management of clinical trials of medicinal products with a view to increasing patient safety.
Questions and Answers
Date answered:
7 February 2002
S1W-22258
Health boards' unified budgets include provision for the cost of prescribed medicines and are set to allow for the introduction of new medicines and the greater use of existing therapies.
Questions and Answers
Date answered:
13 December 2001
S1W-20563
To ask the Scottish Executive what appeals process against its decisions on the approval of medical products is in place. When a medicine receives a UK marketing authorisation, either from the Medicines Control Agency or the European Medicines Evaluation Authority, it becomes...
Questions and Answers
Date answered:
11 February 2000
S1W-04054
The table below shows the number of entrants to medicine courses in Higher Education Institutions in Scotland.
Questions and Answers
Date answered:
7 February 2005
S2W-13712
To ask the Scottish Executive, further to the answer to question S1W-26868 by Malcolm Chisholm on 2 July 2002, what progress has been made in creating a combined community and hospital medicines utilisation database. NHS National Services Scotland (NHS NSS) is establishing a medicines utilisation unit headed by a ch...
Questions and Answers
Date answered:
12 March 2002
S1W-23536
To ask the Scottish Executive what research has been carried out into (a) the short-term and (b) the long-term safety implications of the emergency contraceptive Levonelle. The Medicines Control Agency (MCA) is the UK-wide medicines regulatory authority responsible for ensuring the safety, quality and efficacy of medicines available on the UK market.The MCA has advised that the decision to grant a marketing authorisation in the UK for a product containing levonorgestrel 0.75 mg (emergency hormonal contraceptive) followed advice from the Committee on Safety of Medicines (CSM) who were satisfied as to the product's safety, quality and efficacy.
